| abstract |
A pharmaceutical composition comprising: i) an effective amount of at least one leukotriene antagonist selected from a) montelucast; or b) pranlucast; or one of its pharmaceutically acceptable salts; in admixture with ii) an effective amount of at least one antihistamine that is decarboethoxyloratadine, fexofenadine, ebastine, norastemizole or a pharmaceutically acceptable salt thereof. |